120 Participants Needed

Combination Treatment for Staph Infections

(SHIELD Trial)

LH
MP
Overseen ByMonica Pilewskie, MSPH
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: Johns Hopkins Bloomberg School of Public Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

What is the purpose of this trial?

Indigenous persons experience a high burden of Staphylococcus aureus (SA) invasive disease and skin and soft tissue infections. SA carriage on the skin is factor for development of SA infections. The goal of this clinical trial is to evaluate a community-informed approach to reduce carriage of SA. Participants will be assigned to education and household supplies for prevention of SA with and without a biomedical intervention. Researchers will compare SA carriage in the two groups.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot have used antibiotics in the 30 days before the study starts.

What data supports the effectiveness of the treatment for Staph infections?

Educational interventions, when combined with other strategies, have been shown to positively impact the use of antibiotics and improve prescribing behaviors, suggesting that the educational component of the treatment could enhance its effectiveness.12345

How does the combination treatment for Staph infections differ from other treatments?

This treatment is unique because it combines education and household supplies to prevent Staph infections, focusing on community-based interventions like promoting handwashing with soapy water, which is cost-effective and easy to implement, unlike traditional medical treatments that often rely on antibiotics.678910

Research Team

LH

Laura Hammitt, MD

Principal Investigator

Johns Hopkins Bloomberg School of Public Health

Eligibility Criteria

This trial is for Native American adults living near WMA Tribal lands, aged 18+, with lab-confirmed Staphylococcus aureus (SA) carriage. They must be able to consent and follow the study plan, and have either diabetes, a BMI ≥30, or past SA infections. Excluded are those who've taken antibiotics recently, currently have an SA infection, are related to the study staff, allergic to certain ingredients in the treatments or without a permanent home.

Inclusion Criteria

I have diabetes, a BMI of 30 or higher, or had a skin infection in the last 3 years.
Native American adult living on or adjacent to the WMA Tribal lands
Lab-confirmed SA carriage at time of enrollment
See 2 more

Exclusion Criteria

I haven't taken antibiotics in the last 30 days.
I currently have a Staphylococcus aureus infection.
I am allergic to citrus, Nozin, Hibiclens, or mupirocin.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive education and household supplies, with Group A also receiving a nasal antibiotic and antiseptic regimen

4 months
Visits at baseline, Day 14, Day 30, Day 60, Day 90, and Day 120

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 months

Treatment Details

Interventions

  • Chlorhexidine gluconate
  • Education + Household supplies
  • Mupirocin
  • Nozin
Trial Overview The trial aims to reduce skin SA carriage among participants using two methods: one group receives Mupirocin + Nozin + chlorhexidine gluconate; another gets education plus household supplies for prevention. The effectiveness of these approaches in reducing SA will be compared.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Education + Household supplies + Nasal antibiotic + Antiseptic regimenExperimental Treatment2 Interventions
Participants in this arm will receive education about SA and household supplies (e.g., cleaning products, pump lotion, laundry detergent, towels) plus use of a nasal antibiotic (mupirocin) twice daily for 5 days then maintenance with an antiseptic regimen (Nozin twice daily plus chlorhexidine gluconate wash 3 times per week)
Group II: Education + Household suppliesActive Control1 Intervention
Participants in this arm will receive education about SA and household supplies (e.g., cleaning products, pump lotion, laundry detergent, towels).

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins Bloomberg School of Public Health

Lead Sponsor

Trials
441
Recruited
2,157,000+

National Institute of General Medical Sciences (NIGMS)

Collaborator

Trials
315
Recruited
251,000+

Findings from Research

A combined education and monitoring program significantly improved the appropriate use of gentamicin in a community hospital, increasing valid treatment indications from 75% to 87% among 162 patients studied.
The program also led to a rise in the use of bacteriologic cultures before treatment (from 85% to 97%) and a shift towards less toxic antibiotics (from 36% to 75%), demonstrating that educational interventions can enhance antibiotic prescribing practices.
The effects of monitoring the use of gentamicin in a community hospital.Gilbert, DN., Eubanks, NM., Jackson, JM.[2019]
Antimicrobial resistance is a growing global issue affecting both hospitals and communities, highlighting the need for effective strategies to combat it, especially in community settings.
Educational initiatives targeting both healthcare providers and patients are essential to address antibiotic resistance, as there is a lack of new antibiotics available for community use and for treating resistant infections.
Hospital-based strategies to reduce antibiotic resistance: are they valid in the community setting?Tillotson, GS., Blondeau, JM., Carroll, J.[2019]
The CoMPLI model, a community-wide educational strategy implemented over 6 months, successfully reduced antibiotic claims by nearly 10% in a small Ontario community, indicating improved adherence to clinical guidelines.
Physicians involved in the study were 29% less likely to prescribe second-line antibiotics compared to their peers, demonstrating the effectiveness of the educational interventions in promoting appropriate antibiotic use.
Pilot study for appropriate anti-infective community therapy. Effect of a guideline-based strategy to optimize use of antibiotics.Stewart, J., Pilla, J., Dunn, L.[2018]

References

The effects of monitoring the use of gentamicin in a community hospital. [2019]
Hospital-based strategies to reduce antibiotic resistance: are they valid in the community setting? [2019]
Pilot study for appropriate anti-infective community therapy. Effect of a guideline-based strategy to optimize use of antibiotics. [2018]
The role of education in antimicrobial stewardship. [2021]
Assessing the impact of educational intervention for improving management of malaria and other childhood illnesses in Kibaha District-Tanzania. [2016]
Acceptability and Feasibility of Sharing a Soapy Water System for Handwashing in a Low-Income Urban Community in Dhaka, Bangladesh: A Qualitative Study. [2019]
Provision versus promotion to develop a handwashing station: the effect on desired handwashing behavior. [2018]
The cost-effectiveness of improving malaria home management: shopkeeper training in rural Kenya. [2022]
Development of a community-based maternal, newborn and child emergency training package in South Sudan. [2018]
Effect of Behavior Change Communication on the Incidence of Pneumonia in Under Five Children: A Cluster Randomized Controlled Trial. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security